The Analyst Verdict: Health Catalyst In The Eyes Of 5 Experts
The Analyst Verdict: Health Catalyst In The Eyes Of 5 Experts
分析師意見：health catalyst在5位專家眼中的表現
The...Across the recent three months, 5 analysts have shared their insights on Health Catalyst (NASDAQ:HCAT), expressing a variety of opinions spanning from bullish to bearish.
在最近三個月中，5位分析師分享了他們對Health Catalyst（納斯達克股票代碼：HCAT）的見解，表達了從看漲到看跌的各種觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表簡要介紹了他們最近的評級，展示了過去30天情緒的演變，並將其與前幾個月進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $11.2, along with a high estimate of $16.00 and a low estimate of $7.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 5.08%.
分析師提供了更深入的見解，確定了12個月的目標股價，平均目標價爲11.2美元，最高估計爲16.00美元，低估值爲7.00美元。隨着分析師將平均目標股價下調了5.08％，情緒的負面轉變顯而易見。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析師評級：詳細審查
The...
對...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。